Suchergebnisse

AbstractThe question of misogyny has been well documented in the existing literature on gender and politics, but studies have tended to focus on men's attitudes and discourses toward women and LGBTQI+ issues. In this article, a less common perspective is adopted: that of scrutinising the discourse of what can be labelled anti‐feminist conservative women intellectuals. The article examines what the author calls the UK #MeToo series and how female conservative intellectuals have reacted to it, rejected feminism and, in doing so, women's emancipation more generally. First, three reactionary anti‐feminist discourses around arguments about victimhood, conflation and fear are identified, followed by a discussion of how these anti‐feminist narratives fit into Albert Hirschman's pioneering work on the rhetoric of reaction, but also how they can enrich it. In relation to this, the article considers two reversal or retaliation strategies used by anti‐feminists, consisting first in presenting men as victims and second, in claiming to ally with women against feminism.

Cet article porte sur les formes de production et d'engagement d'un couple de femmes, proche des avant-gardes dans le Paris des années 1920-1930 et du groupe surréaliste en particulier, couple composé de Claude Cahun, pseudonyme de Lucy Schwob (1894-1954) et de Marcel Moore, née Suzanne Malherbe (1892-1972). Il interroge le rôle mutuel joué par chacune d'elle dans la production cahunienne, dans leur engagement anti-fasciste et anti-nazi dans les années 1930-1940 et tente aussi d'éclairer les raisons pour lesquelles Suzanne Malherbe/ Marcel Moore est demeurée effacée par rapport à sa compagne. L'article montre que cet effacement relève du croisement de différents types de contraintes : d'une part, cela résulte d'entraves liées aux difficultés d'accès à la visibilité et à la reconnaissance de femmes artistes, renforcées par le cadre indépassable du génie artistique singulier, susceptibles d'être paradoxalement rejouées par les approches féministe et queer entendant le mettre à mal. D'autre part, cela relève de logiques subjectives propres à l'économie du couple et à la personnalité de chacune.

Cet article analyse le processus de subjectivation féministe de Viola Klein au croisement de son itinéraire et de sa production scientifique. Il s'agit d'abord de rendre compte de la manière dont l'imbrication des rapports de pouvoir intervient dans l'expérience et l'analyse sociologique de Klein tout en se traduisant par une exploration plus spécifique de la féminité. Dans un second temps, le propos s'attache plus spécifiquement au pro­cessus de subjectivation visible dans The Feminine Character, son ouvrage fondateur du féminisme moderne, en rendant compte en particulier des marques subjectives qui se donnent à voir dans le travail de recherche. Enfin, il se propose d'esquisser une généalogie entre la sociologie de la connaissance de Klein et les épistémologies féministes du point de vue et de la connaissance située.

Dans la conclusion de The Feminine Character, Viola Klein revient sur les caractéristiques identifiées chez les auteurs qu'elle a étudiés comme relevant de la féminité. Elle soutient que l'on ne peut déduire de cette étude ce qu'est la féminité, qu'il s'agit d'un concept dépendant des biais personnels, des valeurs et des points de vue sociohistoriques de l'observateur. Elle propose des pistes afin d'évaluer davantage ce qui relève du conditionnement social, comme la comparaison des femmes avec d'autres groupes minorés, ou l'examen des changements dont a fait l'objet le caractère féminin dus à l'évolution sociale. À partir d'exemples historiques, elle suggère également de mesurer les effets du découragement sur la créativité féminine.

Capture, detection and removal of persistent organic pollutants (POPs) from water, air and soil are among the hot topics of research in environmental science. Here we report the first example of indirect ultrasensitive detection of polychlorinated biphenyls in water, obtained by analysing the Raman signals of silver-cyclodextrin supracrystals resulting from drying-induced aggregation of plasmonic alginate bubbles. Principal component analysis allowed to extend the detection limit to the level of 1 ng/L, which is two orders of magnitude lower than that requested by current legislation.

In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organization, and access to patients and their relatives and carers. This issue had a particular regard for cancer patients. Our Thoracic Oncology Division therefore reorganized patient access in order to reduce the risk of contagion and, at the same time, encourage the continuation of treatment. Our staff contacted all patients to inform them of any changes in treatment planning, check that they were taking safety measures, and ascertain their feelings and whether they had any COVID-19 symptoms. To better understand patients' fears and expectations of during the pandemic period, we created a nine-question interview, administered from April to May 2020 to 156 patients with lung cancer. Patients were classified by age, sex, comorbidity, disease stage, prior treatment, and treatment type. The survey showed that during the pandemic period some patients experienced fear of COVID-19, in particular: women (55% vs. 33%), patients with comorbidities (24% vs. 9%), and patients who had already received prior insult (radiotherapy or surgery) on the lung (30% vs. 11%). In addition, the patients who received oral treatment at home or for whom intravenous treatment was delayed, experienced a sense of relief (90% and 72% respectively). However, only 21% of the patients were more afraid of COVID-19 than of their cancer, in particular patients with long-term (> 12 months) vs. short-term cancer diagnosis (28% vs. 12.5%, respectively). Furthermore, the quarantine period or even just the lockdown period alone, worsened the quality of life of some patients (40%), especially those in oral treatment (47%). Our data demonstrate how lung cancer patients are more afraid of their disease than of a world pandemic. Also this interview indirectly highlights the clinician's major guiding principle in ...

In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organization, and access to patients and their relatives and carers. This issue had a particular regard for cancer patients. Our Thoracic Oncology Division therefore reorganized patient access in order to reduce the risk of contagion and, at the same time, encourage the continuation of treatment. Our staff contacted all patients to inform them of any changes in treatment planning, check that they were taking safety measures, and ascertain their feelings and whether they had any COVID-19 symptoms. To better understand patients' fears and expectations of during the pandemic period, we created a nine-question interview, administered from April to May 2020 to 156 patients with lung cancer. Patients were classified by age, sex, comorbidity, disease stage, prior treatment, and treatment type. The survey showed that during the pandemic period some patients experienced fear of COVID-19, in particular: women (55% vs. 33%), patients with comorbidities (24% vs. 9%), and patients who had already received prior insult (radiotherapy or surgery) on the lung (30% vs. 11%). In addition, the patients who received oral treatment at home or for whom intravenous treatment was delayed, experienced a sense of relief (90% and 72% respectively). However, only 21% of the patients were more afraid of COVID-19 than of their cancer, in particular patients with long-term (> 12 months) vs. short-term cancer diagnosis (28% vs. 12.5%, respectively). Furthermore, the quarantine period or even just the lockdown period alone, worsened the quality of life of some patients (40%), especially those in oral treatment (47%). Our data demonstrate how lung cancer patients are more afraid of their disease than of a world pandemic. Also this interview indirectly highlights the clinician's major guiding principle in correctly and appropriately managing not just the patient's expectations of their illness and its treatment, but also and especially of the patient's fears.